WASHINGTON, Sept 23 (Reuters) - Gilead Sciences Inc GILD.O has agreed to pay $97 million to resolve claims that it illegally used a foundation as a conduit to pay the copays of thousands of Medicare patients taking Gilead's pulmonary arterial hypertension drug Letairis, the Justice Department said on Wednesday.
(Reporting by Mohammad Zargham)
((mohammad.zargham@thomsonreuters.com;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.